Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14944739 | 0.97 | — | — | |
| SCHEMBL16351610 | 0.79 | POLB (0.33) | POLBTDP1 | |
| SCHEMBL16351582 | 0.79 | POLB (0.40) | POLBTDP1 | |
| SCHEMBL16351603 | 0.79 | POLB (0.45) | POLBCTDSP1TDP1 | |
| SCHEMBL16351611 | 0.75 | POLB (0.38) | POLBTDP1 | |
| SCHEMBL16351618 | 0.74 | POLB (0.36) | POLBTDP1 | |
| SCHEMBL12269118 | 0.74 | — | — | |
| SCHEMBL16351624 | 0.74 | POLB (0.36) | POLBTDP1 | |
| SCHEMBL12221572 | 0.74 | GABRR1 (0.32) | — | |
| SCHEMBL16351593 | 0.73 | POLB (0.35) | POLBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230265247-A1 | PROCESS FOR PREPARING POLYIMIDES | TECHNISCHE UNIVERSITÄT WIEN (AT) | 2023-08-24 | — | — | US | disclosed |
| US-20150056367-A1 | COMPOSITION FOR FORMING LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY ELEMENT | SOKI CORPORATION (JP) | 2015-02-26 | — | — | US | disclosed |
| US-20140378645-A1 | LIQUID CRYSTAL ALIGNING AGENT | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2014-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140378645-A1 | LIQUID CRYSTAL ALIGNING AGENT | CYP17A1, AUP1, NR5A1 | POLB 846/4885CTDSP1 30/4885TDP1 2030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.